Table 1 Baseline Characteristics of Primary Bladder Cancer Patients

Age - yr (mean)

65.2 ± 12.0

64.1 ± 13.3

0.51*

Gender - no. of patients (%)

0.93⁺

   Male

135 (81.8)

88 (82.2)

   Female

30 (18.2)

19 (17.8)

Grade - no. of patients (%)

0.76⁺

   Low

105 (63.6)

70 (65.4)

   High

60 (36.4)

37 (34.6)

Stage - no. of patients (%)

0.14⁺

   NMIBC

103 (62.4)

76 (71.0)

Ta

   23 (22.3)

   21 (27.6)

T1

   80 (77.7)

   55 (72.4)

   MIBC

62 (37.6)

31 (29.0)

T2N0M0

   26 (41.9)

   8 (25.8)

T3 N0M0

   13 (21.0)

   8 (25.8)

T4/Any T N+/M+

   23 (37.1)

   15 (48.4)

Recurrence - no. of patients with NMIBC (%)

0.94⁺

   No

67 (65.0)

49 (64.5)

   Yes

36 (35.0)

27 (35.5)

Progression - no. of patients (%)

   NMIBC

0.97⁺

No

92 (89.3)

68 (89.5)

Yes

11 (10.7)

8 (10.5)

   MIBC

1.00⁺

No

42 (67.7)

21 (67.7)

Yes

20 (32.3)

10 (32.3)

Survival - no. of patients with MIBC (%)

   Cancer-specific

0.18⁺

Alive

33 (53.2)

21 (67.7)

Deceased

29 (46.8)

10 (32.3)

   Overall survival

0.37⁺

Alive

28 (45.2)

11 (35.5)

Deceased

34 (54.8)

20 (64.5)

Mean follow-up - months

48.4

42.5

0.25*